These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. SARS-CoV-2 RNA polymerase as target for antiviral therapy. Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM J Transl Med; 2020 May; 18(1):185. PubMed ID: 32370758 [TBL] [Abstract][Full Text] [Related]
24. International Expansion of a Novel SARS-CoV-2 Mutant. Wang M; Li M; Ren R; Li L; Chen EQ; Li W; Ying B J Virol; 2020 Jun; 94(12):. PubMed ID: 32269121 [No Abstract] [Full Text] [Related]
25. Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring. Krishan K; Kanchan T Acta Biomed; 2020 Sep; 91(3):e2020023. PubMed ID: 32921745 [TBL] [Abstract][Full Text] [Related]
27. Clinical Trials of Repurposed Antivirals for SARS-CoV-2. Martinez MA Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631826 [TBL] [Abstract][Full Text] [Related]
28. Polyunsaturated fatty acid biosynthesis pathway and genetics. implications for interindividual variability in prothrombotic, inflammatory conditions such as COVID-19 Kothapalli KSD; Park HG; Brenna JT Prostaglandins Leukot Essent Fatty Acids; 2020 Nov; 162():102183. PubMed ID: 33038834 [TBL] [Abstract][Full Text] [Related]
29. Specialized pro-resolving mediator network: an update on production and actions. Chiang N; Serhan CN Essays Biochem; 2020 Sep; 64(3):443-462. PubMed ID: 32885825 [TBL] [Abstract][Full Text] [Related]
30. Consideration of Pannexin 1 channels in COVID-19 pathology and treatment. Swayne LA; Johnstone SR; Ng CS; Sanchez-Arias JC; Good ME; Penuela S; Lohman AW; Wolpe AG; Laubach VE; Koval M; Isakson BE Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L121-L125. PubMed ID: 32519892 [No Abstract] [Full Text] [Related]
31. Acidic electrolyzed water potently inactivates SARS-CoV-2 depending on the amount of free available chlorine contacting with the virus. Takeda Y; Uchiumi H; Matsuda S; Ogawa H Biochem Biophys Res Commun; 2020 Sep; 530(1):1-3. PubMed ID: 32828268 [TBL] [Abstract][Full Text] [Related]
32. Eicosanoids: The Overlooked Storm in Coronavirus Disease 2019 (COVID-19)? Hammock BD; Wang W; Gilligan MM; Panigrahy D Am J Pathol; 2020 Sep; 190(9):1782-1788. PubMed ID: 32650004 [TBL] [Abstract][Full Text] [Related]
33. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection. Gallo CG; Fiorino S; Posabella G; Antonacci D; Tropeano A; Pausini E; Pausini C; Guarniero T; Hong W; Giampieri E; Corazza I; Loiacono R; Loggi E; de Biase D; Zippi M; Lari F; Zancanaro M Prostaglandins Other Lipid Mediat; 2022 Apr; 159():106619. PubMed ID: 35032665 [TBL] [Abstract][Full Text] [Related]
34. Assessment of Polyunsaturated Fatty Acids on COVID-19-Associated Risk Reduction. Baral PK; Amin MT; Rashid MMO; Hossain MS Rev Bras Farmacogn; 2022; 32(1):50-64. PubMed ID: 34876760 [TBL] [Abstract][Full Text] [Related]
35. Susceptibility of SARS-CoV-2 to UV irradiation. Heilingloh CS; Aufderhorst UW; Schipper L; Dittmer U; Witzke O; Yang D; Zheng X; Sutter K; Trilling M; Alt M; Steinmann E; Krawczyk A Am J Infect Control; 2020 Oct; 48(10):1273-1275. PubMed ID: 32763344 [TBL] [Abstract][Full Text] [Related]
36. Acute severe SARS COVID-19 patients produce pro-resolving lipids mediators and eicosanoids. Regidor PA; De La Rosa X; Santos FG; Rizo JM; Gracia Banzo R; Silva RS Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6782-6796. PubMed ID: 34787883 [TBL] [Abstract][Full Text] [Related]
37. Correlation between bioactive lipids and novel coronavirus: constructive role of biolipids in curbing infectivity by enveloped viruses, centralizing on EPA and DHA. Aryan H; Saxena A; Tiwari A Syst Microbiol Biomanuf; 2021; 1(2):186-192. PubMed ID: 38624677 [TBL] [Abstract][Full Text] [Related]
38. Ageing: Is there a role for arachidonic acid and other bioactive lipids? A review. Das UN J Adv Res; 2018 May; 11():67-79. PubMed ID: 30034877 [TBL] [Abstract][Full Text] [Related]
39. Chemically Diverse and Biologically Active Secondary Metabolites from Marine Shah SAA; Hassan SSU; Bungau S; Si Y; Xu H; Rahman MH; Behl T; Gitea D; Pavel FM; Corb Aron RA; Pasca B; Nemeth S Mar Drugs; 2020 Sep; 18(10):. PubMed ID: 32993146 [TBL] [Abstract][Full Text] [Related]
40. A defect in the activities of Δ and Δ desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease. Das UN World J Diabetes; 2011 Nov; 2(11):176-88. PubMed ID: 22087354 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]